rediff.com
e.g. Tata motors, Reliance MF, 500570
Aarti Pharmalabs Ltd. - Research Center
543748 AARTIPHARM Group (A) BSE data
Add to watchlist
 
Back to Company Page
Results
Statement
More
Profit loss account
(Rs crore)
Mar ' 24 Mar ' 23 Mar ' 22 Mar ' 21
Income
Operating income 1,502.13 1,511.25 941.02 -
Expenses
Material consumed 751.97 759.17 491.80 -
Manufacturing expenses 82.92 282.54 167.97 -
Personnel expenses 130.33 122.16 79.98 -
Selling expenses 6.40 5.13 0.31 -
Adminstrative expenses 184.35 33.92 21.16 -
Expenses capitalised - - - -
Cost of sales 1,155.97 1,202.91 761.24 -
Operating profit 346.16 308.34 179.79 -
Other recurring income 11.01 1.28 2.51 -
Adjusted PBDIT 357.17 309.62 182.30 -
Financial expenses 16.63 20.49 11.34 -
Depreciation 66.01 55.77 37.23 -
Other write offs - - - -
Adjusted PBT 274.52 233.36 133.73 -
Tax charges 73.87 61.63 27.00 -
Adjusted PAT 200.65 171.73 106.73 -
Non recurring items - - - -
Other non cash adjustments - - - -
Reported net profit 200.65 171.73 106.73 -
Earnigs before appropriation 1,060.19 877.67 705.95 -0.02
Equity dividend 18.13 18.13 - -
Preference dividend - - - -
Dividend tax - - - -
Retained earnings 1,042.07 859.55 705.95 -0.02
Close
Add Aarti Pharmalabs Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Aarti Pharmalabs Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close